Omeros Corporation (FRA:3O8)
10.11
-0.14 (-1.37%)
At close: Jan 23, 2026
Omeros Employees
Omeros had 202 employees as of December 31, 2024. The number of employees increased by 4 or 2.02% compared to the previous year.
Employees
202
Change (1Y)
4
Growth (1Y)
2.02%
Revenue / Employee
n/a
Profits / Employee
€511,207
Market Cap
697.62M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 202 | 4 | 2.02% |
| Dec 31, 2023 | 198 | 2 | 1.02% |
| Dec 31, 2022 | 196 | -17 | -7.98% |
| Dec 31, 2021 | 213 | -64 | -23.10% |
| Dec 31, 2020 | 277 | 19 | 7.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Paul Hartmann AG | 10,082 |
| FRoSTA Aktiengesellschaft | 1,760 |
| Maschinenfabrik Berthold Hermle AG | 1,607 |
| Südwestdeutsche Salzwerke AG | 1,186 |
| EUROKAI GmbH & Co. KGaA | 950 |
| tonies SE | 567 |
| Northern Data AG | 199 |
| Berliner Effektengesellschaft AG | 163 |
Omeros News
- 4 weeks ago - Commit To Buy Omeros At $10, Earn 26.6% Annualized Using Options - Nasdaq
- 4 weeks ago - Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA - Nasdaq
- 4 weeks ago - Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (Rating Upgrade) - Seeking Alpha
- 5 weeks ago - Omeros Announces New Date for YARTEMLEA Approval Conference Call - Wallstreet:Online
- 5 weeks ago - Omeros Announces New Date for YARTEMLEA® Approval Conference Call - Business Wire
- 5 weeks ago - Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
- 5 weeks ago - Nike, Omeros Corporation, Micron Technology, Intel And Dynavax Technologies: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
- 5 weeks ago - Why Omeros Stock Skyrocketed Today - The Motley Fool